造血干细胞移植后出血并发症管理中国专家共识(2021年版)

2021-04-30 中华医学会血液学分会 中华血液学杂志.2021,42(4):276-280.

造血干细胞移植后出血涉及多器官、多系统,移植后特殊的机体免疫及造血微环境使得出血的诊断和治疗更为复杂和棘手。目前国内外对于造血干细胞移植后出血的管理尚无指南/共识。结合近年来国内外研究成果及移植现状,

中文标题:

造血干细胞移植后出血并发症管理中国专家共识(2021年版)

发布日期:

2021-04-30

简要介绍:

造血干细胞移植后出血涉及多器官、多系统,移植后特殊的机体免疫及造血微环境使得出血的诊断和治疗更为复杂和棘手。目前国内外对于造血干细胞移植后出血的管理尚无指南/共识。结合近年来国内外研究成果及移植现状,中华医学会血液学分会组织国内相关血液学专家制订本共识,为造血干细胞移植后出血并发症的诊疗提供临床指导。

下载附件:

(因为版权问题,不支持下载)

评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1083701, encodeId=39371083e0192, content=牛, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85e91537175, createdName=RENYUQIONG200798, createdTime=Thu Dec 23 22:38:58 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069635, encodeId=c9ba1069635e3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72d85688426, createdName=ms2000000129746485, createdTime=Fri Nov 12 13:56:49 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066882, encodeId=ff6c106688211, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211028/1e6bd3cfdbea45cd9111f9548626d470/a99e858b87e346c2b51ffc96965c28ba.jpg, createdBy=3b7b5651639, createdName=香草🌿, createdTime=Thu Nov 04 11:34:18 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056529, encodeId=ffc01056529a2, content=好文章,学习一下。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Thu Sep 30 16:29:04 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004060, encodeId=db92100406034, content=<a href='/topic/show?id=6ce49500242' target=_blank style='color:#2F92EE;'>#造血干细胞移植#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95002, encryptionId=6ce49500242, topicName=造血干细胞移植)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Fri Jul 30 22:10:41 CST 2021, time=2021-07-30, status=1, ipAttribution=)]
    2021-12-23 RENYUQIONG200798

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1083701, encodeId=39371083e0192, content=牛, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85e91537175, createdName=RENYUQIONG200798, createdTime=Thu Dec 23 22:38:58 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069635, encodeId=c9ba1069635e3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72d85688426, createdName=ms2000000129746485, createdTime=Fri Nov 12 13:56:49 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066882, encodeId=ff6c106688211, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211028/1e6bd3cfdbea45cd9111f9548626d470/a99e858b87e346c2b51ffc96965c28ba.jpg, createdBy=3b7b5651639, createdName=香草🌿, createdTime=Thu Nov 04 11:34:18 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056529, encodeId=ffc01056529a2, content=好文章,学习一下。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Thu Sep 30 16:29:04 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004060, encodeId=db92100406034, content=<a href='/topic/show?id=6ce49500242' target=_blank style='color:#2F92EE;'>#造血干细胞移植#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95002, encryptionId=6ce49500242, topicName=造血干细胞移植)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Fri Jul 30 22:10:41 CST 2021, time=2021-07-30, status=1, ipAttribution=)]
    2021-11-12 ms2000000129746485

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1083701, encodeId=39371083e0192, content=牛, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85e91537175, createdName=RENYUQIONG200798, createdTime=Thu Dec 23 22:38:58 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069635, encodeId=c9ba1069635e3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72d85688426, createdName=ms2000000129746485, createdTime=Fri Nov 12 13:56:49 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066882, encodeId=ff6c106688211, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211028/1e6bd3cfdbea45cd9111f9548626d470/a99e858b87e346c2b51ffc96965c28ba.jpg, createdBy=3b7b5651639, createdName=香草🌿, createdTime=Thu Nov 04 11:34:18 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056529, encodeId=ffc01056529a2, content=好文章,学习一下。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Thu Sep 30 16:29:04 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004060, encodeId=db92100406034, content=<a href='/topic/show?id=6ce49500242' target=_blank style='color:#2F92EE;'>#造血干细胞移植#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95002, encryptionId=6ce49500242, topicName=造血干细胞移植)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Fri Jul 30 22:10:41 CST 2021, time=2021-07-30, status=1, ipAttribution=)]
    2021-11-04 香草🌿

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1083701, encodeId=39371083e0192, content=牛, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85e91537175, createdName=RENYUQIONG200798, createdTime=Thu Dec 23 22:38:58 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069635, encodeId=c9ba1069635e3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72d85688426, createdName=ms2000000129746485, createdTime=Fri Nov 12 13:56:49 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066882, encodeId=ff6c106688211, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211028/1e6bd3cfdbea45cd9111f9548626d470/a99e858b87e346c2b51ffc96965c28ba.jpg, createdBy=3b7b5651639, createdName=香草🌿, createdTime=Thu Nov 04 11:34:18 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056529, encodeId=ffc01056529a2, content=好文章,学习一下。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Thu Sep 30 16:29:04 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004060, encodeId=db92100406034, content=<a href='/topic/show?id=6ce49500242' target=_blank style='color:#2F92EE;'>#造血干细胞移植#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95002, encryptionId=6ce49500242, topicName=造血干细胞移植)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Fri Jul 30 22:10:41 CST 2021, time=2021-07-30, status=1, ipAttribution=)]
    2021-09-30 13f0c37dm61暂无昵称

    好文章,学习一下。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1083701, encodeId=39371083e0192, content=牛, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85e91537175, createdName=RENYUQIONG200798, createdTime=Thu Dec 23 22:38:58 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069635, encodeId=c9ba1069635e3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72d85688426, createdName=ms2000000129746485, createdTime=Fri Nov 12 13:56:49 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066882, encodeId=ff6c106688211, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211028/1e6bd3cfdbea45cd9111f9548626d470/a99e858b87e346c2b51ffc96965c28ba.jpg, createdBy=3b7b5651639, createdName=香草🌿, createdTime=Thu Nov 04 11:34:18 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056529, encodeId=ffc01056529a2, content=好文章,学习一下。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Thu Sep 30 16:29:04 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004060, encodeId=db92100406034, content=<a href='/topic/show?id=6ce49500242' target=_blank style='color:#2F92EE;'>#造血干细胞移植#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95002, encryptionId=6ce49500242, topicName=造血干细胞移植)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Fri Jul 30 22:10:41 CST 2021, time=2021-07-30, status=1, ipAttribution=)]

拓展阅读

2015 ASBMT指南:造血干细胞移植治疗多发性骨髓瘤

美国血液与骨髓移植学会(ASBMT,American Society for Blood and Marrow Transplantation) · 2015-03-10

2016 ECIL-5建议:血液恶性肿瘤以及接受造血干细胞移植患者病毒性肝炎的管理

欧洲白血病感染会议(ECIL,European Conference on Infections in Leukaemia) · 2016-05-01

2018 EBMT立场声明:造血干细胞移植后患者腺病毒感染的管理

欧洲血液和骨髓移植小组(EBMT,European Group for Blood and Marrow Transplantation) · 2018-04-16